Viewing Study NCT06094868


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-28 @ 4:44 AM
Study NCT ID: NCT06094868
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-23
First Post: 2023-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer
Sponsor: Second Affiliated Hospital of Nanchang University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-10
Start Date Type: ESTIMATED
Primary Completion Date: 2026-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-10
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-11
First Submit QC Date: None
Study First Post Date: 2023-10-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-10-17
Last Update Post Date: 2023-10-23
Last Update Post Date Type: ACTUAL